SIC 8731
Services-Commercial Physical & Biological Research
15 companies · 0 with disclosed financials
Total revenue (latest)
—
Total net income
$1.28B
Avg net margin
—
Median net margin
—
5-year industry trend
Total revenue summed across 15 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1MEDPMedpace Holdings, Inc.
$12.36B cap
—
revenue
- 2OABIOmniAb, Inc.
$384.2M cap
—
revenue
- 3MXCTMAXCYTE, INC.
$111.9M cap
—
revenue
- 4BIAFbioAffinity Technologies, Inc.
—
revenue
- 5NOTVInotiv, Inc.
$9.4M cap
—
revenue
- 6INCYINCYTE CORP
$19.41B cap · $303.3M NI
—
revenue
- 7CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.
$7.34B cap · $132.2M NI
—
revenue
- 8BUDZWEED, INC.
$5.0M cap
—
revenue
- 9ISPCiSpecimen Inc.
—
revenue
- 10CBIHCannabis Bioscience International Holdings, Inc.
$3.5M cap
—
revenue
- 11IQVIQVIA HOLDINGS INC.
$32.07B cap · $846.0M NI
—
revenue
- 12ONMDOneMedNet Corp
—
revenue
- 13NRCNRC HEALTH
$430.0M cap
—
revenue
- 14ABSIAbsci Corp
$795.1M cap
—
revenue
- 15FOXOFOXO TECHNOLOGIES INC.
—
revenue
Insider activity in this industry · last 12 months
Insider buying
$5.7M
Insider selling
$392.9M
Net flow
−$387.2M
Distinct insiders
51
Open-market trades summed across all 6 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
About the Services-Commercial Physical & Biological Research industry on ActaClear
ActaClear tracks 15 US-listed public companies classified under SEC SIC code 8731 (Services-Commercial Physical & Biological Research).
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.